Literature DB >> 17329131

Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomised controlled trials.

J Wind1, M J W Koelemay.   

Abstract

OBJECTIVE: To review the evidence for the effectiveness of exercise therapy and to estimate the additional effect of supervision on exercise therapy in patients with intermittent claudication.
MATERIALS AND METHODS: A systematic review was performed of all randomised controlled trials (RCTs) comparing supervised exercise therapy to unsupervised exercise regimens or observation in patients with intermittent claudication. Main endpoints were pain free walking distance (PWD) and absolute walking distance (AWD). Quality assessment and data extraction were performed independently by two observers.
RESULTS: Fifteen manuscripts, published between 1990 and May 2006, were eligible for analysis, evaluating 761 patients. In the studies comparing supervised exercise to standard care the weighted mean difference in pain free walking distance (PWD) and absolute walking distance (AWD) was 81.3meters (95% CI; 35.5-127.1) and 155.8meters (95% CI; 80.8-230.7), respectively. In the studies comparing supervised to unsupervised exercise therapy, the weighted mean difference in PWD and AWD was 143.8meters (95% CI; 5.8-281.8) and 250.4meters (95% CI; 192.4-308.5).
CONCLUSION: Exercise therapy increases the PWD and AWD in patients with intermittent claudication. Supervised exercise therapy increases the PWD and AWD more than standard care. However, the additional value of supervision over unsupervised exercise regimens needs further clarification.

Entities:  

Mesh:

Year:  2007        PMID: 17329131     DOI: 10.1016/j.ejvs.2006.12.030

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  13 in total

Review 1.  Peripheral arterial disease.

Authors:  Kevin Cassar
Journal:  BMJ Clin Evid       Date:  2007-07-01

2.  Supervised exercise for intermittent claudication - an under-utilised tool.

Authors:  Joseph Shalhoub; Maher Hamish; Alun H Davies
Journal:  Ann R Coll Surg Engl       Date:  2009-06-25       Impact factor: 1.891

Review 3.  Peripheral arterial disease.

Authors:  Kevin Cassar
Journal:  BMJ Clin Evid       Date:  2011-01-11

Review 4.  Percutaneous versus surgical management of lower extremity peripheral artery disease.

Authors:  Amit M Kakkar; J Dawn Abbott
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

5.  Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Kristy J Scott; Steve M Blevins
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690

6.  Optimal exercise program length for patients with claudication.

Authors:  Andrew W Gardner; Polly S Montgomery; Donald E Parker
Journal:  J Vasc Surg       Date:  2012-03-28       Impact factor: 4.268

7.  Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Steve M Blevins
Journal:  J Vasc Surg       Date:  2013-11-15       Impact factor: 4.268

8.  Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews.

Authors:  W Darlene Reid; Cristiane Yamabayashi; Donna Goodridge; Frank Chung; Michael A Hunt; Darcy D Marciniuk; Dina Brooks; Yi-Wen Chen; Alison M Hoens; Pat G Camp
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-05-14

Review 9.  Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.

Authors:  David Hageman; Hugo Jp Fokkenrood; Lindy Nm Gommans; Marijn Ml van den Houten; Joep Aw Teijink
Journal:  Cochrane Database Syst Rev       Date:  2018-04-06

10.  Effect of aspirin versus clopidogrel on walking exercise performance in intermittent claudication-a double-blind randomized multicenter trial.

Authors:  Elisabeth Singer; Stephan Imfeld; Daniel Staub; Ulrich Hoffmann; Ivo Buschmann; Karl-Heinz Labs; Kurt A Jaeger
Journal:  J Am Heart Assoc       Date:  2012-02-20       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.